Now showing items 1-12 of 12
| Title | Author(s) | Journal | Issue Date | Type |
|---|---|---|---|---|
| Concordance between HIV-1 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA | Verhofstede, C.; Brudney, D.; Reynaerts, J.; Vaira, D.; Fransen, K.; De Bel, A.; Seguin-Devaux, C.; De Wit, S.; Vandekerckhove, L.; Geretti, A. M. | HIV Medicine | 2011 | Article |
| Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment | Vandekerckhove, L.; Verhofstede, C.; Demecheleer, E.; De Wit, S.; Florence, E.; Fransen, K.; Moutschen, M.; Mostmans, W.; Kabeya, K.; Mackie, N.; Plum, J.; Vaira, D.; Van Baelen, K.; Vandenbroucke, I.; Van Eygen, V.; Van Marck, H.; Vogelaers, D.; Geretti, A. M.; Stuyver, L. J. | Journal of Antimicrobial Chemotherapy | 2011 | Article |
| HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assays | Vandenbroucke, I.; Van Marck, H.; Mostmans, W.; Van Eygen, V.; Rondelez, E.; Thys, K.; Van Baelen, K.; Fransen, K.; Vaira, D.; Kabeya, K.; De Wit, S.; Florence, E.; Moutschen, M.; Vandekerckhove, L.; Verhofstede, C.; Stuyver, L. | AIDS Research and Therapy | 2010 | Article-E |
| Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database | Ruelle, J.; Roman, F.; Vandenbroucke, A. T.; Lambert, C.; Fransen, K.; Echahidi, F.; Piérard, D.; Verhofstede, C.; Van Laethem, K.; Delforge, M. L.; Vaira, D.; Schmit, J. C.; Goubau, P. | BMC Infectious Diseases | 2008 | Article-E |
| Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006 | Vercauteren, J.; Derdelinckx, I.; Sasse, A.; Bogaert, M.; Ceunen, H.; De Roo, A.; De Wit, S.; Deforche, K.; Echahidi, F.; Fransen, K.; Goffard, J. C.; Goubau, P.; Goudeseune, E.; Yombi, J. C.; Lacor, P.; Liesnard, C.; Moutschen, M.; Pierard, D.; Rens, R.; Schrooten, Y.; Vaira, D.; Van den Heuvel, A.; Van der Gucht, B.; Van Ranst, M.; Van Wijngaerden, E.; Vandercam, B.; Vekemans, M.; Verhofstede, C.; Clumeck, N.; Vandamme, A. M.; Van Laethem, K. | AIDS Research and Human Retroviruses | 2008 | Article |
| Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response [letter] | Derdelinckx, I.; Van Laethem, K.; Maes, B.; Schrooten, Y.; De Wit, S.; Florence, E.; Fransen, K.; García Ribas, S.; Marissens, D.; Moutschen, M.; Vaira, D.; Zissis, G.; Van Ranst, M.; Van Wijngaerden, E.; Vandamme, A. M. | Journal of Acquired Immune Deficiency Syndromes | 2004 | Letter |
| Virologic therapy response significantly correlates with the number of active drugs as evaluated using a LiPA HIV-1 resistance scoring system | Ziermann, R.; Celis, L.; Derdelinckx, I.; Lambert, C.; Veeck, J.; Rizzo, M. G.; Vanderborght, B.; Zissis, G.; Clumeck, N.; Fransen, K.; Vaira, D.; Hendricks, D.; Van Laethem, K.; Vandamme, A. M.; Schmit, J. C.; Knechten, H.; De Luca, A.; Louwagie, J.; Segers, P.; De Boeck, K.; Pottel, H.; De Brauwer, A.; Hulstaert, F. | Journal of Clinical Virology | 2004 | Article |
| Performance of the VERSANT (R) HIV-1 Resistance Assays (LiPA) for detecting drug resistance in therapy-naive patients infected with different HIV-1 subtypes | Derdelinckx, I.; Van Laethem, K.; Maes, B.; Schrooten, Y.; De Schouwer, K.; De Wit, S.; Fransen, K.; Ribas, S. G.; Moutschen, M.; Vaira, D.; Zissis, G.; Van Ranst, M.; Van Wijngaerden, E.; Vandamme, A. M. | FEMS Immunology and Medical Microbiology | 2003 | Article |
| Resistance testing in children changing human immunodeficiency virus type 1 protease inhibitor | Servais, J.; Hainaut, M.; Schmitz, V.; Maes, P.; Fransen, K.; Vaira, D.; Brichard, B.; Arendt, V.; Schneider, F.; Hemmer, R.; Schmit, J. C. | Pediatric Infectious Diseases Journal | 2002 | Article |
| Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1 infected patients in Belgium | Van Vaerenbergh, K.; Debaisieux, L.; De Cabooter, N.; Declercq, C.; Desmet, K.; Fransen, K.; Maes, B.; Marissens, D.; Miller, K.; Muyldermans, G.; Sprecher, S.; Stuyver, L.; Vaira, D.; Verhofstede, C.; Zissis, G.; Van Ranst, M.; De Clercq, E.; Desmyter, J.; Vandamme, A. M. | Antiviral Therapy | 2001 | Article |
| Blinded, multicenter quality control study for the quantification of human immunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference laboratories | Muyldermans, G.; Debaisieux, L.; Fransen, K.; Marissens, D.; Miller, K.; Vaira, D.; Vandamme, A. M.; Vandenbroucke, A. T.; Verhofstede, C.; Schuurman, R.; Zissis, G.; Lauwers, S. | Clinical Microbiology and Infection | 2000 | Article |
| Standardization of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harbouring strains of diverse geographical origin | Vandamme, A. M.; Fransen, K.; Debaisieux, L.; Marissens, D.; Sprecher, S.; Vaira, D.; Vandenbroucke, A. T.; Verhofstede, C. | Journal of Virological Methods | 1995 | Article |
Now showing items 1-12 of 12